LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

UNH

363.82

-1.87%↓

AZN

181.33

-1.06%↓

Home・Lista de Ações・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Fechado

SetorSaúde

511.43 -1.3

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

511.43

Máximo

517.85

Indicadores-chave
By Trading Economics
Rendimento	56M -59M
Vendas	34M 321M
Margem de lucro	-18.243
Funcionários	915
EBITDA	56M -50M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+28.57% upside

Dividendos
By Dow Jones
Próximos Ganhos	6 de mai. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	1.4B 12B
Abertura anterior	512.73
Fecho anterior	511.43

Sentimento de Notícias

By Acuity

35%

65%

136 / 347 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

263.2 / 277.1 Suporte e Resistência

Madrigal Pharmaceuticals Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de mai. de 2026, 23:43 UTC

Notícias Principais

New Zealand's Unemployment Rate Falls in 1Q

5 de mai. de 2026, 23:20 UTC

Ações em Alta

Stocks to Watch: AMD, Super Micro, Arista Networks, Freshworks

5 de mai. de 2026, 21:48 UTC

Ganhos

Suncor Energy Reports Higher 1Q Profit on Increased Oil Production

5 de mai. de 2026, 21:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Canada Antitrust Watchdog Seeks to Kibosh Keyera Deal for Plains' Canada Gas Business -- 4th Update

6 de mai. de 2026, 00:00 UTC

Conversa de Mercado

Canada Energy Minister Signals Energy Investments in the Pipeline -- Market Talk

5 de mai. de 2026, 23:39 UTC

Conversa de Mercado

Gold Rises; Trump Pauses 'Project Freedom' to See if Iran Deal Can Be Finalized -- Market Talk

5 de mai. de 2026, 22:26 UTC

Conversa de Mercado

AMD Data-Center Business Continues to Surge -- Market Talk

5 de mai. de 2026, 22:20 UTC

Conversa de Mercado

AMD's AI Revolution is Still in Early Innings, Analysts Say -- Market Talk

5 de mai. de 2026, 22:08 UTC

Ganhos

Correction to "Palantir Beats Forecasts" on May 4. -- WSJ

5 de mai. de 2026, 22:07 UTC

Ganhos

AMD Stock Soars on Strong Earnings and Growing Confidence About AI -- Barrons.com

5 de mai. de 2026, 21:48 UTC

Ganhos

Pan American Silver 1Q Adj EPS $1.09 >PAAS

5 de mai. de 2026, 21:48 UTC

Ganhos

Pan American Silver 1Q Rev $1.2B >PAAS

5 de mai. de 2026, 21:42 UTC

Ganhos

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5 de mai. de 2026, 21:38 UTC

Ganhos

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5 de mai. de 2026, 21:30 UTC

Ganhos

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5 de mai. de 2026, 21:29 UTC

Ganhos

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5 de mai. de 2026, 21:26 UTC

Ganhos

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Falls. -- Barrons.com

5 de mai. de 2026, 21:25 UTC

Ganhos

Alcon Inc. 1Q EPS 39c >ALC.EB

5 de mai. de 2026, 21:25 UTC

Ganhos

Alcon Inc. 1Q Rev $2.71B >ALC.EB

5 de mai. de 2026, 21:24 UTC

Ganhos

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5 de mai. de 2026, 21:18 UTC

Ganhos

Mistras Backs 2026 Rev $730M-$750M >MG

5 de mai. de 2026, 21:17 UTC

Ganhos

AMD Stock Jumps on Solid Earnings. AI Continues to Drive Data Center Chips. -- Barrons.com

5 de mai. de 2026, 21:15 UTC

Ganhos

Strategy Records Loss of Nearly $13 Billion as Bitcoin Continues Decline -- WSJ

5 de mai. de 2026, 21:12 UTC

Ganhos

These Stocks Are Today's Movers: Intel, PayPal, Palantir, Shopify, Micron, Duolingo, and More -- Barrons.com

5 de mai. de 2026, 21:11 UTC

Ganhos

SSR Mining 1Q Rev $581.8M >SSRM

5 de mai. de 2026, 21:10 UTC

Ganhos

SSR Mining 1Q Adj EPS $1.15 >SSRM

5 de mai. de 2026, 21:10 UTC

Ganhos

SSR Mining 1Q EPS $1.16 >SSRM

5 de mai. de 2026, 21:08 UTC

Ganhos

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5 de mai. de 2026, 21:01 UTC

Ganhos

Intact Financial 1Q EPS C$4.12 >IFC.T

5 de mai. de 2026, 21:01 UTC

Ações em Alta

Stocks to Watch Recap: Palantir, AMD, Intel, HSBC -- WSJ

Comparação entre Pares

Variação de preço

Madrigal Pharmaceuticals Inc Previsão

Preço-alvo

By TipRanks

28.57% parte superior

Previsão para 12 meses

Média 666.83 USD 28.57%

Máximo 964 USD

Mínimo 536 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Madrigal Pharmaceuticals Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

Comprar

Manter

Vender

Com base em 7 analistas que deram avaliações de ações para Madrigal Pharmaceuticals Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

263.2 / 277.1Suporte e Resistência

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Sentimento

By Acuity

136 / 347 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.